Ovarian Neoplasms

"Ovarian Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.

Descriptor ID	D010051
MeSH Number(s)	C04.588.322.455 C13.351.500.056.630.705 C13.351.937.418.685 C19.344.410 C19.391.630.705
Concept/Terms	Ovarian Neoplasms Ovarian Neoplasms Neoplasm, Ovarian Ovarian Neoplasm Ovary Neoplasms Neoplasm, Ovary Neoplasms, Ovary Ovary Neoplasm Neoplasms, Ovarian Ovary Cancer Ovary Cancer Cancer, Ovary Cancers, Ovary Ovary Cancers Ovarian Cancer Cancer, Ovarian Cancers, Ovarian Ovarian Cancers Cancer of Ovary Cancer of the Ovary

Below are MeSH descriptors whose meaning is more general than "Ovarian Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Endocrine Gland Neoplasms [C04.588.322]
Ovarian Neoplasms [C04.588.322.455]
Female Urogenital Diseases and Pregnancy Complications [C13]
Female Urogenital Diseases [C13.351]
Genital Diseases, Female [C13.351.500]
Adnexal Diseases [C13.351.500.056]
Ovarian Diseases [C13.351.500.056.630]
Ovarian Neoplasms [C13.351.500.056.630.705]
Urogenital Neoplasms [C13.351.937]
Genital Neoplasms, Female [C13.351.937.418]
Ovarian Neoplasms [C13.351.937.418.685]
Endocrine System Diseases [C19]
Endocrine Gland Neoplasms [C19.344]
Ovarian Neoplasms [C19.344.410]
Gonadal Disorders [C19.391]
Ovarian Diseases [C19.391.630]
Ovarian Neoplasms [C19.391.630.705]

Below are MeSH descriptors whose meaning is more specific than "Ovarian Neoplasms".

Ovarian Neoplasms
Granulosa Cell Tumor
Hereditary Breast and Ovarian Cancer Syndrome
Luteoma
Meigs Syndrome
Sertoli-Leydig Cell Tumor
Thecoma

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Ovarian Neoplasms" by people in this website by year, and whether "Ovarian Neoplasms" was a major or minor topic of these publications.

Bar chart showing 2131 publications over 31 distinct years, with a maximum of 111 publications in 2007

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1991	22	1	23
1992	24	3	27
1993	26	7	33
1994	32	5	37
1995	22	12	34
1996	29	5	34
1997	21	8	29
1998	41	10	51
1999	38	12	50
2000	49	7	56
2001	57	7	64
2002	60	7	67
2003	65	17	82
2004	76	3	79
2005	82	10	92
2006	84	8	92
2007	101	10	111
2008	80	10	90
2009	65	13	78
2010	90	9	99
2011	81	15	96
2012	79	15	94
2013	84	11	95
2014	88	4	92
2015	86	13	99
2016	96	14	110
2017	67	10	77
2018	56	7	63
2019	84	7	91
2020	70	2	72
2021	14	0	14

Below are the most recent publications written about "Ovarian Neoplasms" by people in Profiles.

Ramirez PT. Standardizing ovarian cancer surgery and peri-operative care: a European Society of Gynecological Oncology (ESGO) consensus statement. Int J Gynecol Cancer. 2021 09; 31(9):1207-1208.

View in: PubMed
Elsherif SB, Bhosale PR, Lall C, Menias CO, Itani M, Butler KA, Ganeshan D. Current update on malignant epithelial ovarian tumors. Abdom Radiol (NY). 2021 06; 46(6):2264-2280.

View in: PubMed
Ganeshan D. Introduction to the special section on ovarian cancer. Abdom Radiol (NY). 2021 06; 46(6):2263.

View in: PubMed
Nitecki R, Clapp MA, Fu S, Lamiman K, Melamed A, Brady PC, Kaimal A, Del Carmen MG, Woodard TL, Meyer LA, Giordano SH, Ramirez PT, Rauh-Hain JA. Outcomes of the First Pregnancy After Fertility-Sparing Surgery for Early-Stage Ovarian Cancer. Obstet Gynecol. 2021 06 01; 137(6):1109-1118.

View in: PubMed
Swisher EM, Kwan TT, Oza AM, Tinker AV, Ray-Coquard I, Oaknin A, Coleman RL, Aghajanian C, Konecny GE, O'Malley DM, Leary A, Provencher D, Welch S, Chen LM, Wahner Hendrickson AE, Ma L, Ghatage P, Kristeleit RS, Dorigo O, Musafer A, Kaufmann SH, Elvin JA, Lin DI, Chambers SK, Dominy E, Vo LT, Goble S, Maloney L, Giordano H, Harding T, Dobrovic A, Scott CL, Lin KK, McNeish IA. Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2). Nat Commun. 2021 05 03; 12(1):2487.

View in: PubMed
Cho MS, Li J, Gonzalez-Delgado R, Lee H, Vasquez M, He T, He Y, Liu K, Sasano T, Nürnberg B, Sood AK, Wong STC, Afshar-Kharghan V. The effect of platelet G proteins on platelet extravasation and tumor growth in the murine model of ovarian cancer. Blood Adv. 2021 04 13; 5(7):1947-1951.

View in: PubMed
Itani M, Lalwani N, Ganeshan D, Zulfiqar M, Siegel C. Current update on the molecular genetics and management of hereditary ovarian cancers: a primer for radiologists. Abdom Radiol (NY). 2021 06; 46(6):2281-2292.

View in: PubMed
Javadi S, Ganeshan DM, Jensen CT, Iyer RB, Bhosale PR. Comprehensive review of imaging features of sex cord-stromal tumors of the ovary. Abdom Radiol (NY). 2021 04; 46(4):1519-1529.

View in: PubMed
Elsayed AM, Bayraktar E, Amero P, Salama SA, Abdelaziz AH, Ismail RS, Zhang X, Ivan C, Sood AK, Lopez-Berestein G, Rodriguez-Aguayo C. PRKAR1B-AS2 Long Noncoding RNA Promotes Tumorigenesis, Survival, and Chemoresistance via the PI3K/AKT/mTOR Pathway. Int J Mol Sci. 2021 Feb 13; 22(4).

View in: PubMed
Harrison RF, Fu S, Sun CC, Zhao H, Lu KH, Giordano SH, Meyer LA. Patient cost sharing during poly(adenosine diphosphate-ribose) polymerase inhibitor treatment in ovarian cancer. Am J Obstet Gynecol. 2021 07; 225(1):68.e1-68.e11.

View in: PubMed

People

Explore

Similar Concepts

Top Journals